Triple-Negative Breast Cancer: Adjuvant Therapeutic Options
Chemotherapy Research and Practice · 2011
DOI: 10.1155/2011/696208 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemotherapy Research and Practice, 2011. Verfasst von Ayca Gucalp und 1 weiteren Autor:innen. Beteiligte Einrichtung: Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY 10065, USA. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC), a subtype distinguished by negative immunohistochemical assays for expression of the estrogen and progesterone receptors (ER/PR) and human epidermal growth factor receptor-2(HER2) represents 15% of all breast cancers. Patients with TNBC generally experience a more aggressive clinical course with increased risk of disease progression and poorer overall survival. Furthermore, this subtype accounts for a disproportionate number of disease-related mortality in part due to its aggressive natural history and our lack of effective targeted agents beyond conventional cytotoxic chemotherapy. In this paper, we will review the epidemiology, risk factors, prognosis, and the molecular and clinicopathologic features that distinguish TNBC from other subtypes of breast cancer. In addition, we will examine the available data for the use of cytotoxic chemotherapy in the treatment of TNBC in both the neoadjuvant and adjuvant setting and explore the ongoing development of newer targeted agents.
Autor:innen und Institutionen
- Breast Cancer Medicine Service, Memorial Sloan-Kettering Cancer Center (MSKCC), New York, NY 10065, USA.
Zitieren
APA
Gucalp, A., & Traina, T. A. (2011). Triple-Negative Breast Cancer: Adjuvant Therapeutic Options. Chemotherapy Research and Practice. https://doi.org/10.1155/2011/696208
Vancouver
Gucalp A, Traina TA. Triple-Negative Breast Cancer: Adjuvant Therapeutic Options. Chemotherapy Research and Practice. 2011. doi:10.1155/2011/696208
BibTeX
@article{Gucalp2011,
author = {Gucalp, Ayca and Traina, Tiffany A},
title = {Triple-Negative Breast Cancer: Adjuvant Therapeutic Options},
journal = {Chemotherapy Research and Practice},
year = {2011},
doi = {10.1155/2011/696208}
}
EUVIMED